| Purpose | Announcement Date | Ex-Date | Record Date | Dividend Amount | Dividend per Share | Remark |
|---|---|---|---|---|---|---|
| Dividend | 22 May 2026 | 22 Sep 2026 | 22 Sep 2026 | 0.4 | 40 | Final |
| Recommended the Final Dividend of Rs.0.40 Paise (i.e., 40%) per equity share of face value of Rs.1/-each for the financial year 2025-26, subject to approval of the members at the ensuing Annual General Meeting (AGM). The Company has fixed Wednesday 16th September, 2026 as the Record Date for the purpose of determining the Members eligible to receive dividend for the financial year 2025-26, if approved at the ensuing AGM and the same will be paid within the stipulated time period (As Per BSE Announcement Dated on:31.07.2026) Record date for Dividend has been changed from 16th September, 2026 to 22nd September, 2026. (As Per BSE Announcement Dated on:27.08.2026) | ||||||
SMS Pharma added that it will submit its formal response to the USFDA within the stipulated timeline, in line with standard regulatory practice.
For the June quarter, SMS Pharma reported a 24.3% year-on-year jump in net profit to ₹20.49 crore, compared with ₹16.48 crore a year earlier.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.